{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:14:54Z","timestamp":1787022894352,"version":"build-2736575974"},"reference-count":27,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,1,1]]},"abstract":"<jats:p>Objective. To assess the therapeutic effects of breathing a low-density gas mixture (heliox: 70% helium and 30% oxygen) in infants with bronchiolitis.<\/jats:p>\n                  <jats:p>Design. Prospective, interventional, comparative study.<\/jats:p>\n                  <jats:p>Setting. A pediatric intensive care unit (PICU) in a tertiary care, teaching hospital.<\/jats:p>\n                  <jats:p>Patients. Thirty-eight infants, 1 month to 2 years old, consecutively admitted to the PICU for treatment of moderate-to-severe acute respiratory syncytial virus bronchiolitis.<\/jats:p>\n                  <jats:p>Interventions. The first 19 patients were enrolled as the control group and received supportive care and nebulized epinephrine. In the next 19 patients, heliox therapy was added through a nonrebreather reservoir face mask.<\/jats:p>\n                  <jats:p>Measurements and Outcomes. Respiratory distress score, respiratory rate, heart rate, end-tidal CO2 (etCO2), and pulse oximetry oxygen saturation (satO2) values were recorded at baseline and at regular intervals. Data obtained during the first 4 hours were analyzed for comparison purposes. Demographic data, age, time elapsed from the start of the symptoms to the admission to PICU, length of stay in PICU (PICU-LOS), and duration of heliox therapy were also collected for each patient. Reductions in clinical scores and PICU-LOS were considered primary outcomes.<\/jats:p>\n                  <jats:p>Main Results. At baseline, the heliox and control groups had similar age (5.5 \u00b1 3.1 vs 5.9 \u00b1 3 months), previous length of course (47.3 \u00b1 19.3 vs 45.4 \u00b1 18.6 hours), clinical score (6.7 \u00b1 1.1 vs 6.6 \u00b1 1), heart rate (160 \u00b1 24 vs 165 \u00b1 20 beats per minute), respiratory rate (64 \u00b1 7 vs 61 \u00b1 7 respirations per minute), satO2 (91 \u00b1 2.3 vs 91 \u00b1 2.5%), and etCO2 (34 \u00b1 7 vs 33 \u00b1 6 mm Hg). Clinical score, heart rate, respiratory rate, and satO2 improved during the study in both groups. After 1 hour, the improvement in clinical score was significantly higher in the heliox group than in the control group (3.6 \u00b1 1.16 vs 5.5 \u00b1 0.89), and these differences continued to be significant at the end of the observation period (2.39 \u00b1 0.69 and 4.07 \u00b1 0.96, respectively), with a total average decrease in the score of 4.2 points in the heliox group versus 2.5 points in the control group. Heart and respiratory rates were also significantly lower in the heliox group compared with the control group after 1 hour and stayed lower throughout the rest of the study period. No changes were noted either in satO2 between groups or in etCO2 within or between groups throughout the study. Mean duration of heliox administration was 53 \u00b1 24 hours (range: 24\u2013112 hours) and no adverse effects were detected. PICU-LOS was significantly shorter in the heliox group (3.5 \u00b1 1.1 days) than in the control group (5.4 \u00b1 1.6 days).<\/jats:p>\n                  <jats:p>Conclusions. In infants with moderate-to-severe respiratory syncytial virus bronchiolitis, heliox therapy enhanced their clinical respiratory status, according to the marked improvement in their clinical scores and the reduction of the accompanying tachycardia and tachypnea. This beneficial response occurred within the first hour of its administration and was maintained as long as heliox therapy continued. In addition, PICU-LOS was reduced in heliox-treated patients. Long-term prospective studies are required to corroborate these findings and to establish the proper place of heliox in the therapeutic schedule of bronchiolitis.<\/jats:p>","DOI":"10.1542\/peds.109.1.68","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T20:17:55Z","timestamp":1092428275000},"page":"68-73","source":"Crossref","is-referenced-by-count":117,"title":["Heliox Therapy in Infants With Acute Bronchiolitis"],"prefix":"10.1542","volume":"109","author":[{"given":"Federico","family":"Martino\u0301n-Torres","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rodri\u0301guez-Nu\u0301n\u0303ez","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Mari\u0301a","family":"Martino\u0301n-Sa\u0301nchez","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2002,1,1]]},"reference":[{"key":"2021121021225038900_R1","doi-asserted-by":"crossref","unstructured":"Barach AL. The use of helium in the treatment of asthma and obstructive lesions in the larynx and trachea. Ann Intern Med.1935;9:739\u2013765","DOI":"10.7326\/0003-4819-9-6-739"},{"key":"2021121021225038900_R2","doi-asserted-by":"crossref","unstructured":"Barach AL. The therapeutic use of helium. JAMA.1936;107:1273\u20131275","DOI":"10.1001\/jama.1936.02770420011003"},{"key":"2021121021225038900_R3","unstructured":"Martino\u0301n-Torres F, Nun\u0303ez AR, Martino\u0301n JM. Heliox: perspectivas de aplicacio\u0301n en pediatri\u0301a. An Esp Ped.1999;128(suppl):42S\u201345S"},{"key":"2021121021225038900_R4","unstructured":"Martino\u0301n-Torres F. Otros modos de terapia respiratoria: heliox. In: Ruza Tarri\u0301o F, ed. Tratado de Cuidados Intensivos Pediatricos. Madrid, Spain: Norma-Capitel; In press"},{"key":"2021121021225038900_R5","unstructured":"Manthous CA, Morgan S, Pohlman A, Hall JB. Heliox in the treatment of airflow obstruction: a critical review of the literature. Respir Care.1997;42:1034\u20131042"},{"key":"2021121021225038900_R6","doi-asserted-by":"crossref","unstructured":"Papamoschou D. Theoretical validation of the respiratory benefits of helium-oxygen mixtures. Respir Physiol.1995;99:183\u2013190","DOI":"10.1016\/0034-5687(94)00071-7"},{"key":"2021121021225038900_R7","doi-asserted-by":"crossref","unstructured":"Tobias JD. Heliox in children with airway obstruction. Pediatr Emerg Care.1997;13:29\u201332","DOI":"10.1097\/00006565-199702000-00010"},{"key":"2021121021225038900_R8","doi-asserted-by":"crossref","unstructured":"Manthous CA, Hall JB, Caputo MA, et al. Heliox improves pulsus paradoxus and peak expiratory flow in nonitubated patients with severe asthma. Am J Respir Crit Care Med.1995;151:310\u2013314","DOI":"10.1164\/ajrccm.151.2.7842183"},{"key":"2021121021225038900_R9","doi-asserted-by":"crossref","unstructured":"Terregino CA, Nairn SJ, Chansky ME, Kass JE. The effect of heliox on croup: a pilot study. Acad Emerg Med.1998;5:1130\u20131133","DOI":"10.1111\/j.1553-2712.1998.tb02680.x"},{"key":"2021121021225038900_R10","doi-asserted-by":"crossref","unstructured":"Rodeberg DA, Easter AJ, Washam MA, Housinger TA, Greenhalgh DG, Warden GD. Use of a helium-oxygen mixture in the treatment of postextubation stridor in pediatric patients with burns. J Burn Care Rehabil.1995;16:476\u2013480","DOI":"10.1097\/00004630-199509000-00003"},{"key":"2021121021225038900_R11","doi-asserted-by":"crossref","unstructured":"Kass JE, Terregino CA. The effect of heliox in acute severe asthma: a randomized controlled trial. Chest.1999;116:296\u2013300","DOI":"10.1378\/chest.116.2.296"},{"key":"2021121021225038900_R12","doi-asserted-by":"crossref","unstructured":"Kudukis TM, Manthous CA, Schmidt GA, et al. Inhaled helium-oxygen revisited: effect of inhaled helium-oxygen during the treatment of status asthmaticus in children. J Pediatr.1997;130:217\u2013224","DOI":"10.1016\/S0022-3476(97)70346-9"},{"key":"2021121021225038900_R13","doi-asserted-by":"crossref","unstructured":"Tassaux D, Jolliet P, Roeseler J, Chevrolet JC. Effects of helium-oxygen on intrinsic positive end-expiratory pressure in intubated and mechanically ventilated patients with severe chronic obstructive pulmonary disease. Crit Care Med.2000;28:2721\u20132728","DOI":"10.1097\/00003246-200008000-00006"},{"key":"2021121021225038900_R14","doi-asserted-by":"crossref","unstructured":"Jolliet P, Tassaux D, Thouret JM, Chevrolet JC. Beneficial effects of helium:oxgen vs air:oxygen nonivasive pressure support in patients with decompensated chronic obstructive pulmonary disease. Crit Care Med.1999;27:2422\u20132429","DOI":"10.1097\/00003246-199911000-00017"},{"key":"2021121021225038900_R15","doi-asserted-by":"crossref","unstructured":"Outwater MK, Crone RK. Management of respiratory failure in infants with acute bronchiolitis. Am J Dis Child.1984;138:1071\u20131075","DOI":"10.1001\/archpedi.1984.02140490071018"},{"key":"2021121021225038900_R16","doi-asserted-by":"crossref","unstructured":"Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr.1995;126:212\u2013219","DOI":"10.1016\/S0022-3476(95)70547-3"},{"key":"2021121021225038900_R17","doi-asserted-by":"crossref","unstructured":"Paret G Dekel B, Vardi A, Szeinberg A, Lotan D, Barzilay Z. Heliox in respiratory failure secondary to bronchiolitis: a new therapy. Pediatr Pulmonol.1996;22:322\u201323","DOI":"10.1002\/(SICI)1099-0496(199611)22:5<322::AID-PPUL6>3.0.CO;2-M"},{"key":"2021121021225038900_R18","doi-asserted-by":"crossref","unstructured":"Hollman G, Shen G, Zeng L, et al. Helium-oxygen improves Clinical Asthma Scores in children with acute bronchiolitis. Crit Care Med.1998;26:1731\u20131736","DOI":"10.1097\/00003246-199810000-00031"},{"key":"2021121021225038900_R19","doi-asserted-by":"crossref","unstructured":"Wood DW, Downes JJ, Lecks HI. A clinical scoring system for the diagnosis of respiratory failure. Am J Dis Child.1972;123:227\u2013228","DOI":"10.1001\/archpedi.1972.02110090097011"},{"key":"2021121021225038900_R20","doi-asserted-by":"crossref","unstructured":"Tal A, Bavilski C, Yohai D, Bearman JE, Gorodischer R, Moses SW. Dexamethasone and salbutamol in the treatment of acute wheezing in infants. Pediatrics.1983;71:13\u201318","DOI":"10.1542\/peds.71.1.13"},{"key":"2021121021225038900_R21","doi-asserted-by":"crossref","unstructured":"Schuh S, Canny G, Reisman JJ, et al. Nebulized albuterol in acute bronchiolitis. J Pediatr.1990;117:633\u2013637","DOI":"10.1016\/S0022-3476(05)80706-1"},{"key":"2021121021225038900_R22","unstructured":"O\u2019Brodovich HM, Haddad GC. The functional basis of respiratory pathology and disease. In: Chernick V, Boat TF, eds. Kendig\u2019s Disorders of the Respiratory Tract in Children. Philadelphia, PA: WB Saunders; 1998:27\u201374"},{"key":"2021121021225038900_R23","doi-asserted-by":"crossref","unstructured":"Shay DK, Holman RC, Roosevelt GE, Clarke MJ, Anderson LJ. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979\u20131997. J Infect Dis.2001;183:16\u201322","DOI":"10.1086\/317655"},{"key":"2021121021225038900_R24","doi-asserted-by":"crossref","unstructured":"Deschildre A, Thumerelle C, Bruno B, Dubos F, Santos C, Dumonceaux A. Acute bronchiolitis in infants. Arch Pediatr.2000;7(suppl):21S\u201326S","DOI":"10.1016\/S0929-693X(00)88814-4"},{"key":"2021121021225038900_R25","unstructured":"Leon MC, Dorao Martinez-Romillo P, Garcia Garcia S, Ruza Tarrio F. Prevention and therapy of bronchiolitis: current status. An Esp Pediatr.1998;49:451\u2013455"},{"key":"2021121021225038900_R26","doi-asserted-by":"crossref","unstructured":"Wood LDH, Engel LA, Griffin P. Effect of gas physical properties and flow on lower pulmonary resistance. J Appl Physiol.1976;41:234\u2013244","DOI":"10.1152\/jappl.1976.41.2.234"},{"key":"2021121021225038900_R27","doi-asserted-by":"crossref","unstructured":"Mink S, Wood LDH. How does HeO2 increase maximum expiratory flow in human lungs?J Clin Invest.1980;66:720\u2013729","DOI":"10.1172\/JCI109909"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/109\/1\/68\/986852\/68.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/109\/1\/68\/986852\/68.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T01:56:10Z","timestamp":1639187770000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/109\/1\/68\/79726\/Heliox-Therapy-in-Infants-With-Acute-Bronchiolitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2002,1,1]]},"published-print":{"date-parts":[[2002,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.109.1.68","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1,1]]}}}